{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:50:16Z","timestamp":1772164216575,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371905"],"award-info":[{"award-number":["82371905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2021Y9154"],"award-info":[{"award-number":["2021Y9154"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2021Y9093"],"award-info":[{"award-number":["2021Y9093"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01886-9","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:33:38Z","timestamp":1756107218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiparametric MRI for differential diagnosis of primary central nervous system lymphoma and atypical glioblastoma: an analysis incorporating DWI, DCE-MRI, and contrast agent preload DSC-PWI"],"prefix":"10.1186","volume":"25","author":[{"given":"Lan","family":"Yu","sequence":"first","affiliation":[]},{"given":"Shujie","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Xiaofang","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Feiman","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Dairong","family":"Cao","sequence":"additional","affiliation":[]},{"given":"Zhen","family":"Xing","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"5","key":"1886_CR1","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1007\/s00415-023-12143-w","volume":"271","author":"ME de Koning","year":"2024","unstructured":"de Koning ME, Hof JJ, Jansen C, et al. Primary central nervous system lymphoma. J Neurol. 2024;271(5):2906\u201313.","journal-title":"J Neurol"},{"issue":"12 Suppl 2","key":"1886_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2016\u20132020. Neuro Oncol. 2023;25(12 Suppl 2):iv1\u201399.","journal-title":"Neuro Oncol"},{"issue":"5","key":"1886_CR3","first-page":"e8195","volume":"12","author":"N Grech","year":"2020","unstructured":"Grech N, Dalli T, Mizzi S, et al. Rising incidence of glioblastoma multiforme in a Well-Defined population. Cureus. 2020;12(5):e8195.","journal-title":"Cureus"},{"issue":"7","key":"1886_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: A review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"issue":"6","key":"1886_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3174\/ajnr.A3383","volume":"34","author":"CH Toh","year":"2013","unstructured":"Toh CH, Wei KC, Chang CN, Ng SH, Wong HF. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol. 2013;34(6):1145\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"1886_CR6","doi-asserted-by":"publisher","first-page":"9098","DOI":"10.1007\/s00330-021-08044-z","volume":"31","author":"KM Kang","year":"2021","unstructured":"Kang KM, Choi SH, Chul-Kee P, et al. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI. Eur Radiol. 2021;31(12):9098\u2013109.","journal-title":"Eur Radiol"},{"issue":"3","key":"1886_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiol.14132740","volume":"272","author":"P Kickingereder","year":"2014","unstructured":"Kickingereder P, Wiestler B, Sahm F, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. Radiology. 2014;272(3):843\u201350.","journal-title":"Radiology"},{"issue":"8","key":"1886_CR8","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1007\/s00330-023-09681-2","volume":"33","author":"X Yu","year":"2023","unstructured":"Yu X, Hong W, Ye M, et al. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling. Eur Radiol. 2023;33(8):5357\u201367.","journal-title":"Eur Radiol"},{"key":"1886_CR9","doi-asserted-by":"publisher","first-page":"811197","DOI":"10.3389\/fonc.2022.811197","volume":"12","author":"Y Han","year":"2022","unstructured":"Han Y, Wang ZJ, Li WH, et al. Differentiation between primary central nervous system lymphoma and atypical glioblastoma based on MRI morphological feature and signal intensity ratio: A retrospective multicenter study. Front Oncol. 2022;12:811197.","journal-title":"Front Oncol"},{"issue":"4","key":"1886_CR10","doi-asserted-by":"publisher","first-page":"e15150","DOI":"10.1016\/j.heliyon.2023.e15150","volume":"9","author":"A Feng","year":"2023","unstructured":"Feng A, Li L, Huang T, et al. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study. Heliyon. 2023;9(4):e15150.","journal-title":"Heliyon"},{"key":"1886_CR11","doi-asserted-by":"crossref","unstructured":"Saini J, Kumar Gupta P, Awasthi A, et al. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI. Clin Radiol. 2018;73(11):986.e987-986.e915.","DOI":"10.1016\/j.crad.2018.07.107"},{"issue":"8","key":"1886_CR12","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3174\/ajnr.A3915","volume":"35","author":"P Kickingereder","year":"2014","unstructured":"Kickingereder P, Sahm F, Wiestler B, et al. Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation. AJNR Am J Neuroradiol. 2014;35(8):1503\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"1886_CR13","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3174\/ajnr.A6761","volume":"41","author":"A Pons-Escoda","year":"2020","unstructured":"Pons-Escoda A, Garcia-Ruiz A, Naval-Baudin P, et al. Presurgical identification of primary central nervous system lymphoma with normalized Time-Intensity curve: A pilot study of a new method to analyze DSC-PWI. AJNR Am J Neuroradiol. 2020;41(10):1816\u201324.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1886_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/jmri.26602","volume":"50","author":"CH Suh","year":"2019","unstructured":"Suh CH, Kim HS, Jung SC, et al. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis. J Magn Reson Imaging. 2019;50(2):560\u201372.","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"1886_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1148\/radiographics.17.6.9397461","volume":"17","author":"KK Koeller","year":"1997","unstructured":"Koeller KK, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: radiologic-pathologic correlation. Radiographics. 1997;17(6):1497\u2013526.","journal-title":"Radiographics"},{"issue":"3","key":"1886_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neurad.2010.06.004","volume":"38","author":"V Dandois","year":"2011","unstructured":"Dandois V, De Coene B, Laloux P, Godfraind C, Cosnard G. Increased relative cerebral blood volume (rCBV) in brain lymphoma. J Neuroradiol. 2011;38(3):191\u20133.","journal-title":"J Neuroradiol"},{"issue":"1","key":"1886_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-013-1161-z","volume":"114","author":"S Blasel","year":"2013","unstructured":"Blasel S, Jurcoane A, Bahr O, et al. MR perfusion in and around the contrast-enhancement of primary CNS lymphomas. J Neurooncol. 2013;114(1):127\u201334.","journal-title":"J Neurooncol"},{"issue":"3","key":"1886_CR18","first-page":"421","volume":"42","author":"S Hua","year":"2020","unstructured":"Hua S, Liu Y, Chen Z. [Supratentorial primary central nervous system lymphoma with hyperperfusion:report of one case]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020;42(3):421\u20136.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"8","key":"1886_CR19","first-page":"1415","volume":"39","author":"B Lee","year":"2018","unstructured":"Lee B, Park JE, Bjornerud A, et al. Clinical value of vascular permeability estimates using dynamic susceptibility contrast MRI: improved diagnostic performance in distinguishing hypervascular primary CNS lymphoma from glioblastoma. AJNR Am J Neuroradiol. 2018;39(8):1415\u201322.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"1886_CR20","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.1007\/s00330-023-09917-1","volume":"33","author":"F Wang","year":"2023","unstructured":"Wang F, Zhou X, Chen R, et al. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma. Eur Radiol. 2023;33(12):8800\u20138.","journal-title":"Eur Radiol"},{"issue":"9","key":"1886_CR21","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/neuonc\/noaa141","volume":"22","author":"JL Boxerman","year":"2020","unstructured":"Boxerman JL, Quarles CC, Hu LS, et al. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro Oncol. 2020;22(9):1262\u201375.","journal-title":"Neuro Oncol"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"109784","DOI":"10.1016\/j.ejrad.2021.109784","volume":"141","author":"K Ozturk","year":"2021","unstructured":"Ozturk K, Soylu E, Cayci Z. Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging. Eur J Radiol. 2021;141:109784.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1886_CR23","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1007\/s00330-023-10164-7","volume":"34","author":"EN Cheong","year":"2024","unstructured":"Cheong EN, Park JE, Park SY, Jung SC, Kim HS. Achieving imaging and computational reproducibility on multiparametric MRI radiomics features in brain tumor diagnosis: Phantom and clinical validation. Eur Radiol. 2024;34(3):2008\u201323.","journal-title":"Eur Radiol"},{"issue":"8","key":"1886_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1886_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jmri.1880070113","volume":"7","author":"PS Tofts","year":"1997","unstructured":"Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7(1):91\u2013101.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1886_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1088\/0031-9155\/53\/5\/005","volume":"53","author":"MR Orton","year":"2008","unstructured":"Orton MR, d\u2019Arcy JA, Walker-Samuel S, et al. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI. Phys Med Biol. 2008;53(5):1225\u201339.","journal-title":"Phys Med Biol"},{"issue":"5","key":"1886_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/mrm.21066","volume":"56","author":"GJ Parker","year":"2006","unstructured":"Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med. 2006;56(5):993\u20131000.","journal-title":"Magn Reson Med"},{"issue":"2","key":"1886_CR28","first-page":"167","volume":"16","author":"HJ Weinmann","year":"1984","unstructured":"Weinmann HJ, Laniado M, M\u00fctzel W. Pharmacokinetics of gddtpa\/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR. 1984;16(2):167\u201372.","journal-title":"Physiol Chem Phys Med NMR"},{"issue":"4","key":"1886_CR29","first-page":"859","volume":"27","author":"JL Boxerman","year":"2006","unstructured":"Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27(4):859\u201367.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"1886_CR30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/brainsci10110886","volume":"10","author":"F Eisenhut","year":"2020","unstructured":"Eisenhut F, Schmidt MA, Putz F, et al. Classification of primary cerebral lymphoma and glioblastoma featuring dynamic susceptibility contrast and apparent diffusion coefficient. Brain Sci. 2020;10(11):886.","journal-title":"Brain Sci"},{"issue":"3","key":"1886_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3174\/ajnr.A5023","volume":"38","author":"X Lin","year":"2017","unstructured":"Lin X, Lee M, Buck O, et al. Diagnostic accuracy of T1-Weighted dynamic Contrast-Enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma. AJNR Am J Neuroradiol. 2017;38(3):485\u201391.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"1886_CR32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/neuonc\/noab276","volume":"24","author":"A Hagiwara","year":"2022","unstructured":"Hagiwara A, Oughourlian TC, Cho NS, et al. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2022;24(6):1020\u20138.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1886_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","volume":"1","author":"D Hambardzumyan","year":"2015","unstructured":"Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends Cancer. 2015;1(4):252\u201365.","journal-title":"Trends Cancer"},{"issue":"10","key":"1886_CR34","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.ejrad.2016.07.005","volume":"85","author":"S Lu","year":"2016","unstructured":"Lu S, Gao Q, Yu J, et al. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor. Eur J Radiol. 2016;85(10):1722\u20137.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1886_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223\u201332.","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"1886_CR36","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00330-016-4484-2","volume":"27","author":"YS Choi","year":"2017","unstructured":"Choi YS, Lee HJ, Ahn SS, et al. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient. Eur Radiol. 2017;27(4):1344\u201351.","journal-title":"Eur Radiol"},{"key":"1886_CR37","doi-asserted-by":"crossref","unstructured":"Lee MD, Baird GL, Bell LC, Quarles CC, Boxerman JL. Utility of percentage signal recovery and baseline signal in DSC-MRI optimized for relative CBV measurement for differentiating glioblastoma, lymphoma, metastasis, and meningioma. AJNR Am J Neuroradiol. 2019;40(9):1445\u201350.","DOI":"10.3174\/ajnr.A6153"},{"issue":"3","key":"1886_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11060-006-9281-3","volume":"82","author":"Y Sugita","year":"2007","unstructured":"Sugita Y, Takase Y, Mori D, et al. Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. J Neurooncol. 2007;82(3):249\u201356.","journal-title":"J Neurooncol"},{"issue":"1","key":"1886_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12880-020-00462-7","volume":"20","author":"Z Xing","year":"2020","unstructured":"Xing Z, Kang N, Lin Y, et al. Performance of diffusion and perfusion MRI in evaluating primary central nervous system lymphomas of different locations. BMC Med Imaging. 2020;20(1):62.","journal-title":"BMC Med Imaging"},{"issue":"9","key":"1886_CR40","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1007\/s00330-018-5368-4","volume":"28","author":"HB Suh","year":"2018","unstructured":"Suh HB, Choi YS, Bae S, et al. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using radiomics approach. Eur Radiol. 2018;28(9):3832\u20139.","journal-title":"Eur Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01886-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01886-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01886-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:12:48Z","timestamp":1757455968000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01886-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01886-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the First Affiliated Hospital of Fujian Medical University. Individual consent was waived due to the retrospective study design. All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}